$ cat ./records/gates-foundation-pledges-154-million-to-cepi-100-days-mission-for-2022.txt
Gates Foundation Pledges $154 Million to CEPI 100 Days Mission for Pandemic Vaccines in Under 100 Days
[RECORD.TXT] · cat --full
At the Global Pandemic Preparedness Summit in London in March 2022, the Gates Foundation pledged $154 million toward CEPI's 100 Days Mission — the goal of producing safe and effective vaccines against any new pandemic threat within 100 days of pathogen sequencing. Total pledges at the summit exceeded $1.535 billion from governments and organisations. The 100 Days Mission aims to compress the vaccine development timeline from years to under three and a half months, potentially saving millions of lives in a future pandemic through rapid regulatory authorisation and manufacturing scale-up.
Free forever · No ads · Solo developer
If this was worth a read, help make the next entry possible.
Every entry in this archive was researched, verified, and written by one person — for free. No corporate funding. No ad revenue. Just a developer who believes verified history should be accessible to everyone. Your donation directly funds new entries.
Crypto accepted · No subscription required
← Previous
Gates Foundation Commits Up to $125 Million to End Acute COVID-19 Phase and Strengthen Global Disease Monitoring
Next →
Gates Foundation Commits $169 Million to Serum Institute for R21/Matrix-M Malaria Vaccine Manufacturing
[CROSS_REFERENCES] · grep --category='Global Health'
Related Accomplishments
January 2026
Gates-backed World Mosquito Program reaches 16 million people protected from dengue via Wolbachia method
The World Mosquito Program — backed in part by the Gates Foundation — announced in January 2026 that its Wolbachia-infected mosquito releases had reached over 16.1 million people across multiple countries, including Colombia, Indonesia, Brazil, Sri Lanka, Fiji, Vanuatu, and Vietnam. Wolbachia-carrying Aedes aegypti mosquitoes — which block dengue, Zika, chikungunya, and yellow fever transmission — had established self-sustaining populations in treated cities without requiring ongoing releases. Gold-standard randomised trials in Indonesia showed a 77% reduction in dengue incidence. The program represented one of the largest and most cost-effective vector control deployments in history.
2025
Gates-Funded Monoclonal Antibody Shows Early Promise as a Single-Shot Malaria Shield
[ARCHIVE_FUNDING] · INDEPENDENT · NO ADS
One developer. >300 verified entries. Zero ads. Forever free.
No sponsors, no paywall, no algorithm. If this archive has been useful to you, reader support is what keeps it running.